Ankylose This! Living with Ankylosing Spondylitis

Monday, July 31, 2006

FDA approves Humira for AS

The FDA has approved Humira (adalimumab) for the treatment of ankylosing spondylitis, its manufacturer, Abbott Laboratories, reported today. See previous entries: Humira approved for AS in Europe; Humira (adalimumab) and AS: clinical trials.

Update, Aug. 4: Lots of coverage on the financial nets, some on the wire services, but this story from the Worcester Telegram and Gazette is better than most.

Comments on this post

Post a Comment

Links to this post

Create a Link